Eyenovia Inc (EYEN)
0.808
+0.10
(+13.48%)
USD |
NASDAQ |
May 31, 16:00
0.7971
-0.01
(-1.35%)
After-Hours: 20:00
Eyenovia Research and Development Expense (TTM): 14.89M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.89M |
| December 31, 2023 | 12.98M |
| September 30, 2023 | 11.11M |
| June 30, 2023 | 11.41M |
| March 31, 2023 | 12.19M |
| December 31, 2022 | 13.38M |
| September 30, 2022 | 14.47M |
| June 30, 2022 | 14.14M |
| March 31, 2022 | 14.24M |
| December 31, 2021 | 14.85M |
| September 30, 2021 | 15.01M |
| June 30, 2021 | 14.82M |
| March 31, 2021 | 14.05M |
| December 31, 2020 | 13.36M |
| Date | Value |
|---|---|
| September 30, 2020 | 13.24M |
| June 30, 2020 | 13.08M |
| March 31, 2020 | 13.73M |
| December 31, 2019 | 14.10M |
| September 30, 2019 | 14.90M |
| June 30, 2019 | 14.19M |
| March 31, 2019 | 13.03M |
| December 31, 2018 | 11.12M |
| September 30, 2018 | 8.577M |
| June 30, 2018 | 6.660M |
| March 31, 2018 | 5.00M |
| December 31, 2017 | 3.817M |
| September 30, 2017 | 3.214M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
11.11M
Minimum
Sep 2023
15.01M
Maximum
Sep 2021
13.71M
Average
14.08M
Median
Research and Development Expense (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.061M |
| Alpine Immune Sciences Inc (DELISTED) | 83.78M |
| Lantern Pharma Inc | 13.59M |
| Oragenics Inc | 14.48M |
| MAIA Biotechnology Inc | 11.24M |